ALFA FinderBSE filing, NSE: PRUDENT. Summary written from the filing by ALFA Finder's alert engine.
Prudent Corporate Advisory Services Ltd: key numbers
- Share price
- ₹3,011.50
- Market cap
- ₹12,470 Cr
- Revenue (annual)
- ₹1,317 Cr
- Net profit (annual)
- ₹222.1 Cr
- P/E (TTM)
- 47.4×Sector 20.8×
- Promoter holding
- 55.31%+0.00% QoQ
- FII holding
- 14.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prudent Corporate Advisory Services Ltd
All →Prudent Corporate Advisory Services Earnings Call Transcript: Key Takeaways
Prudent delivered record quarterly net sales amidst market volatility, though profit growth was dampened by treasury losses.
Prudent Corporate Advisory Services Capital Structure Change
Prudent Corporate Advisory will invest ₹6.53 Crore in a rights issue of its wholly owned subsidiary Prutech Financial Services. The funds support Prutech's planned portfolio management services expansion.
- Value
- ₹6.53 Cr
Prudent Corporate Advisory Services Employee Stock Options
Prudent Corporate allotted 1,190 equity shares under its ESOP-2025 scheme at an exercise price of ₹2,632 each. The allotment lifts paid-up capital to 4,14,07,870 shares.
Prudent Corporate Advisory Services Results Update
Prudent's Q2 FY27 revenue grew 21.6% YoY to ₹388.7 Cr; PAT rose 33.9% to ₹71.7 Cr. Operating profit jumped 42.4% to ₹102.8 Cr on AUM growth.
Prudent Corporate Advisory Services Investor Presentation: Key Takeaways
Q2 FY27 deck: AUM ₹1,41,026 Cr, 21.6 lakh investors, 39,691 MFDs; equity AUM outgrowing industry (821 vs 589 rebased). No P&L disclosed.
Prudent Corporate Advisory Services Q2 FY27 Results: Net Profit ₹71.7 Cr, Up 34.0% YoY
Prudent Corporate Advisory Services Ltd reported revenue from operations of ₹388.7 Cr (+21.5% YoY) and net profit of ₹71.7 Cr (+34.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹71.7 Cr · +34.0% YoY
Other business update announcements
All →Suven Life Sciences Business Update
Suven Life Sciences will present seven posters on its CNS pipeline at Neuroscience 2026, Washington DC. Presentations span Phase-3 and preclinical candidates targeting neurodegenerative and neuropsychiatric disorders.
Smruthi Organics Business Update
Smruthi Organics received the Brazilian GMP (CBPF) certificate for its Unit II API, Levamlodipine Besylate Hemi pentahydrate. This strengthens its regulatory presence in the Brazilian pharmaceutical market.
Kreon Finnancial Services Business Update
Kreon Financial Services launched StuCred for Startups, a mentorship initiative for student entrepreneurs. No revenue projection or monetary value is attached to the new program.
Aurobindo Pharma Business Update
Aurobindo Pharma disclosed that US FDA classified its Lannett facility inspection as Official Action Indicated (OAI). The company states there is no quantifiable financial or operational impact.
Gokaldas Exports Business Update
Gokaldas Exports issued a press release clarifying a customer's Chapter 11 filing, which involves USD 4.11 million of receivables held by its African subsidiary Atraco. It also reports two new customers onboarded in its African operations.
Adani Enterprises Business Update
Adani Enterprises' Kutch Copper became the first Indian producer to receive the Copper Mark certification. It recognises responsible copper production under independent ESG audits.